Fast Locator 2011-2012: Celsis Analytical Services - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2011-2012: Celsis Analytical Services



Celsis Analytical Services specializes in methods validation and testing for industry offering a wide range of services in analytical chemistry and microbiological testing for compendial, non-compendial, and client-specific needs, plus stability testing and storage programs. And we're up-to-date on ICH and the latest changes to the USP as well as the Ph EUR and JP.

Analytical Chemistry:
Our chemistry department can perform more than 90% of the testing requirements defined in the United States Pharmacopeia (USP) and its counterparts around the globe. We continuously invest in the latest instrumentation, including multiple HPLC, GC, IC and LC-MS/MS plus dissolution and AA. Count on us for your full monograph testing, with confidence.

Biological Sciences:
Our microbiology scientists combine decades of microbiological testing experience in facilities that are equipped with the latest instrumentation and equipment including two Class 100 clean rooms, DiversiLab strain typing System, Vitek 60® Microbial Identification Systems, Celsis Rapid Detection systems and particle size analyzers.

Stability Testing and Storage:
Since the establishment of pharmaceutical expiration dating provisions, we have led the way in supplying the appropriate testing and storage conditions to meet regulatory and customer demands for product and package stability. From photostability to Zone IV conditions, we can handle your stability testing and storage needs.


Regions covered:

Global: Asia, North America, Europe, Latin America.


Outsourcing services provided:

Analytical Services

  • Chemistry and stability
  • Bioanalytical testing
  • Biosafety and product characterization
  • Microbiology
  • Particle characterization

Website:

www.celsis.com/labs

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search

Click here